111 related articles for article (PubMed ID: 11905547)
61. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
[TBL] [Abstract][Full Text] [Related]
62. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
[TBL] [Abstract][Full Text] [Related]
63. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ
Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
[TBL] [Abstract][Full Text] [Related]
64. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.
van Noord JA; Aumann JL; Janssens E; Verhaert J; Smeets JJ; Mueller A; Cornelissen PJ
Chest; 2006 Mar; 129(3):509-17. PubMed ID: 16537846
[TBL] [Abstract][Full Text] [Related]
65. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests.
Oga T; Nishimura K; Tsukino M; Hajiro T; Ikeda A; Izumi T
Am J Respir Crit Care Med; 2000 Jun; 161(6):1897-901. PubMed ID: 10852763
[TBL] [Abstract][Full Text] [Related]
66. Tiotropium bromide: a long-acting anticholinergic bronchodilator for the treatment of patients with chronic obstructive pulmonary disease.
Joos GF; Brusselle G; Derom E; Pauwels R
Int J Clin Pract; 2003 Dec; 57(10):906-9. PubMed ID: 14712894
[TBL] [Abstract][Full Text] [Related]
67. Early bronchodilating effect of oxitropium bromide in comparison with ipratropium bromide.
Lulling J; Delwiche JP; Prignot J
Respiration; 1981; 42(3):188-92. PubMed ID: 6458867
[TBL] [Abstract][Full Text] [Related]
68. Tiotropium in chronic obstructive pulmonary disease.
O'Connor AB
N Engl J Med; 2009 Jan; 360(2):185-6; author reply 187. PubMed ID: 19137624
[No Abstract] [Full Text] [Related]
69. Tiotropium improves FEV1 in patients with COPD irrespective of smoking status.
Moita J; Bárbara C; Cardoso J; Costa R; Sousa M; Ruiz J; Santos ML
Pulm Pharmacol Ther; 2008; 21(1):146-51. PubMed ID: 17693107
[TBL] [Abstract][Full Text] [Related]
70. An acute bronchodilator test with tiotropium or salmeterol does not allow a subdivision of patients according to responses.
Matera MG; Sanduzzi A; Ponticiello A; Vatrella A; Salzillo A; Cazzola M
Respiration; 2005; 72(5):466-70. PubMed ID: 16210884
[TBL] [Abstract][Full Text] [Related]
71. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease].
Zheng JP; Kang J; Cai BQ; Zhou X; Cao ZL; Bai CX; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):363-7. PubMed ID: 17045014
[TBL] [Abstract][Full Text] [Related]
72. Acute bronchodilator responses to β2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation.
Konno S; Makita H; Suzuki M; Shimizu K; Kimura H; Kimura H; Nishimura M;
Respir Med; 2017 Jun; 127():14-20. PubMed ID: 28502414
[TBL] [Abstract][Full Text] [Related]
73. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.
Fabbri LM; Calverley PM; Izquierdo-Alonso JL; Bundschuh DS; Brose M; Martinez FJ; Rabe KF;
Lancet; 2009 Aug; 374(9691):695-703. PubMed ID: 19716961
[TBL] [Abstract][Full Text] [Related]
74. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
[TBL] [Abstract][Full Text] [Related]
75. [The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease].
Ma J; Zhou Z; Tang Y; Zhong N
Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):964-8. PubMed ID: 25623564
[TBL] [Abstract][Full Text] [Related]
76. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.
van Noord JA; Cornelissen PJ; Aumann JL; Platz J; Mueller A; Fogarty C
Respir Med; 2009 Jan; 103(1):22-9. PubMed ID: 19022642
[TBL] [Abstract][Full Text] [Related]
77. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.
Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
Respirology; 2006 Sep; 11(5):598-602. PubMed ID: 16916333
[TBL] [Abstract][Full Text] [Related]
78. A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD.
Quinn D; Seale JP; Reisner C; Fischer T; Golden M; Fernandez C; Darken P; St Rose E; Thomas M; Tardie G; Orevillo C
Respir Med; 2014 Sep; 108(9):1327-35. PubMed ID: 25060541
[TBL] [Abstract][Full Text] [Related]
79. The bronchodilator effects of extrafine glycopyrronium added to combination treatment with beclometasone dipropionate plus formoterol in COPD: A randomised crossover study (the TRIDENT study).
Singh D; Schröder-Babo W; Cohuet G; Muraro A; Bonnet-Gonod F; Petruzzelli S; Hoffmann M; Siergiejko Z;
Respir Med; 2016 May; 114():84-90. PubMed ID: 27109816
[TBL] [Abstract][Full Text] [Related]
80. Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium.
Incorvaia C; Riario-Sforza GG; Pravettoni C; Yacoub MR; Frati F
Int J Chron Obstruct Pulmon Dis; 2008; 3(1):123-6. PubMed ID: 18488435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
